Clinical trial
The Mobile Insulin Titration Intervention (MITI) Study: Innovative Chronic Disease Management of Diabetes
NCT01879579 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Mobile Insulin Titration Intervention (MITI) Study: Innovative Chronic Disease Management of Diabetes
- Lead sponsor
- NYU Langone Health
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 30, 2013
- Completion date
- June 30, 2015
- Enrollment
- 61 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.